0001628280-23-039850.txt : 20231122
0001628280-23-039850.hdr.sgml : 20231122
20231122143142
ACCESSION NUMBER: 0001628280-23-039850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: San Martin Javier
CENTRAL INDEX KEY: 0001794629
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38042
FILM NUMBER: 231432858
MAIL ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: STE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARROWHEAD PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000879407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460408024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
BUSINESS PHONE: 626-696-4702
MAIL ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: SUITE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
FORMER COMPANY:
FORMER CONFORMED NAME: ARROWHEAD RESEARCH CORP
DATE OF NAME CHANGE: 20040112
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE GROUP INC
DATE OF NAME CHANGE: 20020509
FORMER COMPANY:
FORMER CONFORMED NAME: INTERACTIVE INC
DATE OF NAME CHANGE: 19940224
4
1
wk-form4_1700681491.xml
FORM 4
X0508
4
2023-11-20
0
0000879407
ARROWHEAD PHARMACEUTICALS, INC.
ARWR
0001794629
San Martin Javier
177 E. COLORADO BLVD
SUITE 700
PASADENA
CA
91105
0
1
0
0
Chief Medical Officer
1
Common Stock
2023-11-20
4
S
0
14758
28.73
D
136742
D
Common Stock
2023-11-20
4
S
0
4942
29
D
131800
D
The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $27.97 to $28.90, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.15, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
/s/Javier San Martin
2023-11-21